We develop a multiple-events model and exploit within and between country variation in the timing, type and level of intensity of various non-pharmaceutical interventions to study their dynamic effects on the daily incidence of COVID-19 and on population mobility patterns across 135 countries....

We develop a multiple-events model and exploit within and between country variation in the timing, type and level of intensity of various non-pharmaceutical interventions to study their dynamic effects on the daily incidence of COVID-19 and on population mobility patterns across 135 countries....

Over the first half of March 2021, the majority of European governments suspended Astrazeneca's Vaxzevria vaccine as a precaution following media reports of rare blood clots. We analyse the impact of the European Medicines Agency's (EMA) March 18th statement assuring the public of the safety of...

Over the first half of March 2021, the majority of European governments suspended Astrazeneca's Vaxzevria vaccine as a precaution following media reports of rare blood clots. We analyse the impact of the European Medicines Agency's (EMA) March 18th statement assuring the public of the safety of...